PCI 3.06.26

Current Edition

Current Features

Subsection - Neurodegenerative Diseases

From Depression to Deep-Learning: Leveraging iPSC and AI Platforms for Evidence-Based Depression Treatment

Continue reading

Subsection - Oncology

Essential DMPK Strategies for IND Success

Continue reading

Subsection - Cell and Gene Therapy

When the Gene Editing Guide is the Drug

Continue reading

Upcoming Events

CPHI 2027
AI in Drug Discovery
DDL 2026
Biotechnology Show 13.02.26

Advertisement

Advertisement

A&M Stabtest April 26

Advertisement

Biopharma Group – 19th March 2025

Advertisement

Micron View

Advertisement

Bachem skyscraper

Advertisement

Fujifilm
news

Undecimal Bio launches with $18 million oversubscribed Seed financing to address ‘liver trap’ in siRNA therapeutic delivery

·        A spin-out focused on AI-enabled decoding of the deliverome ·        Proprietar...
Continue Reading →
news

Google DeepMind’s Nature Study on Watermarking AI-Designed Proteins Validated with Carterra HT-SPR

New paper published in Nature shows watermarks can be embedded in AI-generated proteins without compromising function, confirmed with binding kinetics data from ...
Continue Reading →
news

Parkinson’s disease market across 7MM to grow to $7.2 billion by 2033, forecasts GlobalData

The Parkinson's disease (PD) market across the seven major markets (7MM*) is forecast to grow at a compound annual growth rate (CAGR) of 7.9%, from $3.3 billion ...
Continue Reading →
news

Amphista Therapeutics announces first patient dosed in AMX-883 Phase 1 clinical trial for acute myeloid leukaemia

AMX-883, Amphista's first asset to enter the clinic, is a potent, selective, orally bioavailable DCAF16-mediated BRD9 degrader targeting acute myeloid leukaemia...
Continue Reading →
news

Carterra advances lab-in-the-loop drug discovery through new scientific collaboration

Bringing together scientific and technical expertise to advance development of hardware and software aimed at enabling a new wave of AI-driven, autonomous biolog...
Continue Reading →
news

ELRIG and The Protein Society Announce Keynote Speakers for Protein Sciences in Drug Discovery 2026

·       Prof Dame Carol Robinson (University of Oxford), Dr Andrew Doré (Isomorphic Labs) and Prof Paula Booth (King’s College Lond...
Continue Reading →
news

Gaelic and Athlone Labs Launch Dual Source Strategy at CPHI Milan

Following a horizontal acquisition in December 2025, the companies are realising marked synergies under an ambitious integration program that has successfully al...
Continue Reading →
news

Cresset launches Flare AI Client, helping computational chemists complete hours of work in minutes

Scientists can now connect company-approved AI providers such as Claude Code and GitHub Copilot directly to Flare, helping teams set up, execute, and analyze com...
Continue Reading →
news

Phillips Medisize to Present Evidence-Based Framework for High-Dose Subcutaneous Drug Delivery at the 2026 Parenteral Drug Association (PDA) Universe of Pre-Filled Syringes and Injection Devices Conference

Phillips Medisize, a Molex company and a leader in the design, development, engineering and manufacturing of pharmaceutical drug delivery, in vitro diagnostic an...
Continue Reading →
news

Olon expands ADC platform in France and doubles US manufacturing capacity

Saint-Julien adds bioconjugation and development capabilities that complement HPAPI andpayload expertise in Rodano, while the Concord, Ohio site doubles producti...
Continue Reading →

Advertisement

Richter: Wed 23 October 2024, 09:03

Advertisement

Aseptic Tech

Advertisement

Steribar – 12.05.2025

Advertisement

PharmExcel

Advertisement

Polypure hompage

Advertisement

Gen Xpro

Advertisement

Alphinity

Advertisement

Crown Bioscience

Advertisement

Shimadzu

Advertisement

CPC